Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04848337
Title Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer (PLANE-PC)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Ulka Vaishampayan
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.